Indonesian Political, Business & Finance News

Chinese researchers treat rare disease with RNA editing technology

| Source: Antara (Indonesian) Translated from Indonesian | Technology
Chinese researchers treat rare disease with RNA editing technology
Image: Antara (Indonesian)

Beijing (ANTARA) - A team of Chinese researchers has treated the rare and severe hereditary disease Duchenne Muscular Dystrophy (DMD) using a new RNA editing technology called LEAPER, the technical details and clinical applications of which were published on Wednesday (10/6) in the journal Cell.

This marks the first time that RNA editing technology developed by China has entered the clinical trial stage, and is also the first time globally that RNA editing has been applied in the treatment of DMD.

DMD is caused by gene mutations, with symptoms including progressive muscle atrophy and loss of motor function. Patients typically begin to show symptoms during childhood, gradually losing the ability to walk, and most die prematurely due to respiratory or heart failure.

Despite being classified as a rare disease, China has one of the largest numbers of DMD patients in the world due to its massive population base.

Current treatments can only partially delay the progression of the disease but cannot reverse its development.

DMD is also widely known as one of the most challenging diseases in the field of gene therapy. The causative gene is too large for conventional gene therapy methods to insert the entire gene into a patient’s body.

Furthermore, different patients can carry more than 7,000 types of pathogenic mutations, meaning a single treatment regimen often only reaches a small fraction of patients. Therefore, developing treatment strategies that combine broad applicability with long-term efficacy remains a major challenge for the global medical community.

The latest RNA editing technology was developed by a team from the Beijing-based Changping Laboratory and Peking University.

According to Wei Wensheng, the team leader, the components of the LEAPER system can accurately identify the problematic genetic “blueprint” in muscle cells, repair the gene by deleting specific sequences, and enable cells to produce functional proteins according to the corrected genetic blueprint, thereby helping muscles regain their vitality.

Unlike traditional approaches, this new technology does not require the delivery of exogenous editing enzymes. Using only a single segment of modified RNA molecule, the technology can mobilise key enzymes naturally contained within human cells to achieve accurate editing of the target RNA. This system is relatively simple with high safety and minimises the delivery burden.

The team has established collaborations with the Kunming University of Science and Technology in southwestern China, Shanghai Jiao Tong University in eastern China, and other institutions to develop drug candidates. Three paediatric patients who have undergone treatment all showed significant and sustained improvements in motor function during a one-year follow-up period.

Xie Xiaoliang, director of the Changping Laboratory and an academic at the Chinese Academy of Sciences, stated that the development and application of the LEAPER platform reflect the laboratory’s commitment to developing new drugs through original basic research and cutting-edge technology. He expressed hope that this new technology could benefit an increasing number of patients suffering from serious diseases.

More from 11 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/chinese-researchers-treat-rare-disease-with-rna-editing-technology-1781172027)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5603948/peneliti-china-obati-penyakit-langka-dengan-teknologi-penyuntingan-rna), translated from Indonesian
Print